Dube Eric M
CIK 0001763494
Chief Executive OfficerDirector
Filings
24
Latest May 6, 2026
Issuers covered
2
Showing
24 of 24
Page 1
Track record
30 of 31 open-market trades scored (97% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 30 | 53% | +0.4% | +0.7% | +44.3% | -40.4% |
| 90 days | 25 | 56% | +0.8% | +3.3% | +55.7% | -47.2% |
| 180 days | 20 | 60% | +2.9% | +14.1% | +42.3% | -61.3% |
| 365 days | 18 | 56% | -19.3% | +17.4% | +61.1% | -137.9% |
Issuers
Companies where Dube Eric M has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | 22 | May 6, 2026 |
| RPHM | Reneo Pharmaceuticals, Inc. | 2 | Jun 8, 2023 |
All filings
24 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|